VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 25 filers reported holding VASCULAR BIOGENICS LTD in Q1 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $852,000 | -49.2% | 120,000 | -56.3% | 0.00% | -50.0% |
| Q3 2017 | $1,676,000 | -42.5% | 274,820 | -58.1% | 0.00% | -42.9% |
| Q2 2017 | $2,917,000 | -40.6% | 655,574 | -26.5% | 0.01% | -41.7% |
| Q1 2017 | $4,908,000 | +9.6% | 892,330 | -3.3% | 0.01% | +9.1% |
| Q4 2016 | $4,478,000 | -7.1% | 923,239 | 0.0% | 0.01% | -8.3% |
| Q3 2016 | $4,819,000 | +13.2% | 923,239 | 0.0% | 0.01% | +9.1% |
| Q2 2016 | $4,256,000 | +524.0% | 923,239 | +371.1% | 0.01% | +450.0% |
| Q1 2016 | $682,000 | -33.9% | 195,966 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $1,031,000 | – | 195,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,896,902 | $4,173,000 | 5.19% |
| Knoll Capital Management, LLC | 896,771 | $1,973,000 | 1.68% |
| SABBY MANAGEMENT, LLC | 1,856,169 | $4,084,000 | 0.63% |
| 683 Capital Management, LLC | 346,574 | $762,000 | 0.05% |
| Virtu Financial LLC | 64,203 | $141,000 | 0.01% |
| Spark Investment Management LLC | 29,300 | $64,000 | 0.00% |
| Alyeska Investment Group, L.P. | 83,333 | $183,000 | 0.00% |
| Burt Wealth Advisors | 1,674 | $4,000 | 0.00% |
| A.R.T. Advisors, LLC | 24,682 | $54,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 29,220 | $64,000 | 0.00% |